Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics
Delta opioid receptors (DORs) are rising as therapeutic targets, not only for the treatment of pain but also other neurological disorders (e.g., Parkinson’s disease). The advantage of DOR agonists compared to μ-opioid receptor agonists is that they have fewer side effects and a lower potential to in...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 September 2024
|
| In: |
ACS chemical biology
Year: 2024, Jahrgang: 19, Heft: 9, Pages: 1963-1981 |
| ISSN: | 1554-8937 |
| DOI: | 10.1021/acschembio.4c00231 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acschembio.4c00231
|
| Verfasserangaben: | Roxana Damiescu, Mona Dawood, Mohamed Elbadawi, Sabine M. Klauck, Gerhard Bringmann, and Thomas Efferth |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 190521328X | ||
| 003 | DE-627 | ||
| 005 | 20241205180128.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241009s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acschembio.4c00231 |2 doi | |
| 035 | |a (DE-627)190521328X | ||
| 035 | |a (DE-599)KXP190521328X | ||
| 035 | |a (OCoLC)1475314405 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Damiescu, Roxana |e VerfasserIn |0 (DE-588)1339188740 |0 (DE-627)1898866848 |4 aut | |
| 245 | 1 | 0 | |a Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics |c Roxana Damiescu, Mona Dawood, Mohamed Elbadawi, Sabine M. Klauck, Gerhard Bringmann, and Thomas Efferth |
| 264 | 1 | |c 20 September 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 21. August 2024 | ||
| 500 | |a Gesehen am 09.10.2024 | ||
| 520 | |a Delta opioid receptors (DORs) are rising as therapeutic targets, not only for the treatment of pain but also other neurological disorders (e.g., Parkinson’s disease). The advantage of DOR agonists compared to μ-opioid receptor agonists is that they have fewer side effects and a lower potential to induce tolerance. However, although multiple candidates have been tested in the past few decades, none have been approved for clinical use. The current study focused on searching for new DOR agonists by screening a chemical library containing 40,000 natural and natural-derived products. The functional activity of the top molecules was evaluated in vitro through the cyclic adenosine monophosphate accumulation assay. Compound 3 showed promising results, and its activity was further investigated through transcriptomic methods. Compound 3 inhibited the expression of TNF-α, prevented NF-κB translocation to the nucleus, and activated the G-protein-mediated ERK1/2 pathway. Additionally, compound 3 is structurally different from known DOR agonists, making it a valuable candidate for further investigation for its anti-inflammatory and analgesic potential. | ||
| 700 | 1 | |a Dawood, Mona |e VerfasserIn |4 aut | |
| 700 | 1 | |a Elbadawi, Mohamed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klauck, Sabine |e VerfasserIn |0 (DE-588)111181967X |0 (DE-627)865928258 |0 (DE-576)476293006 |4 aut | |
| 700 | 1 | |a Bringmann, Gerhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Efferth, Thomas |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Chemical Society |t ACS chemical biology |d Washington, DC : Soc., 2006 |g 19(2024), 9 vom: Sept., Seite 1963-1981 |h Online-Ressource |w (DE-627)507526732 |w (DE-600)2221735-6 |w (DE-576)252159918 |x 1554-8937 |7 nnas |
| 773 | 1 | 8 | |g volume:19 |g year:2024 |g number:9 |g month:09 |g pages:1963-1981 |g extent:19 |a Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics |
| 856 | 4 | 0 | |u https://doi.org/10.1021/acschembio.4c00231 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241009 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 111181967X |a Klauck, Sabine |m 111181967X:Klauck, Sabine |d 50000 |e 50000PK111181967X |k 0/50000/ |p 4 | ||
| 999 | |a KXP-PPN190521328X |e 4589603721 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"origin":[{"publisherPlace":"Washington, DC","dateIssuedKey":"2006","publisher":"Soc.","dateIssuedDisp":"2006-"}],"id":{"eki":["507526732"],"zdb":["2221735-6"],"issn":["1554-8937"]},"name":{"displayForm":["American Chemical Society"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"ACS chemical biology","subtitle":"web edition","title":"ACS chemical biology"}],"pubHistory":["1.2006 -"],"part":{"extent":"19","volume":"19","text":"19(2024), 9 vom: Sept., Seite 1963-1981","pages":"1963-1981","issue":"9","year":"2024"},"titleAlt":[{"title":"Chemical biology"}],"note":["Gesehen am 18.11.08"],"disp":"American Chemical SocietyACS chemical biology","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"507526732","corporate":[{"display":"American Chemical Society","roleDisplay":"VerfasserIn","role":"aut"}],"language":["eng"]}],"physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.1021/acschembio.4c00231"],"eki":["190521328X"]},"origin":[{"dateIssuedDisp":"20 September 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Roxana Damiescu, Mona Dawood, Mohamed Elbadawi, Sabine M. Klauck, Gerhard Bringmann, and Thomas Efferth"]},"language":["eng"],"recId":"190521328X","note":["Online veröffentlicht: 21. August 2024","Gesehen am 09.10.2024"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics","title_sort":"Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Damiescu, Roxana","given":"Roxana","family":"Damiescu"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Dawood, Mona","given":"Mona","family":"Dawood"},{"roleDisplay":"VerfasserIn","display":"Elbadawi, Mohamed","role":"aut","family":"Elbadawi","given":"Mohamed"},{"display":"Klauck, Sabine","roleDisplay":"VerfasserIn","role":"aut","family":"Klauck","given":"Sabine"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bringmann, Gerhard","given":"Gerhard","family":"Bringmann"},{"family":"Efferth","given":"Thomas","roleDisplay":"VerfasserIn","display":"Efferth, Thomas","role":"aut"}]} | ||
| SRT | |a DAMIESCUROIDENTIFICA2020 | ||